key: cord-0886234-qtex4jue
authors: De la Corte‐Rodriguez, Hortensia; Rodriguez‐Merchan, E. Carlos; Alvarez‐Roman, M. Teresa; Jimenez‐Yuste, Víctor
title: Intra‐articular injections in people with haemophilia in the COVID‐19 era
date: 2020-05-19
journal: Haemophilia
DOI: 10.1111/hae.14070
sha: 1950bb2c80ca364aabd4928a423e18fe83ee8e56
doc_id: 886234
cord_uid: qtex4jue

Given the current SARS‐CoV‐2 pandemic, many patients with haemophilia will have close contact with a confirmed case or suffer from coronavirus 2019 respiratory disease (COVID‐19) and will need medical attention. Considering that this situation is exceptional, it is necessary to carry out integrated assistance for patients with haemophilia patients and their relatives, focusing such assistance on all the dimensions of life. In this regard, the WFH's recommendations to optimise haematological prophylaxis and its adherence should be emphasised to minimise the risk of bleeding and thus reduce the need to visit health care facilities [1].

Article type : Letter to the Editor 7 8 9

Letter to the Editor (HAE-00223-2020): REVISION-1 10

This article is protected by copyright. All rights reserved aim to provide guidance on what measures should be taken to care for patients with 59 haemophilia who require intra-articular injections in the current COVID-19 context. 60 61 It should be noted that, today, there are no solid references or experiences on how to 62 undertake the normalisation of care. In any case, the adoption of the recommended 63 measures will have to be individualised for each patient and adapted to the guidelines of 64 the government, professional associations, and care centres, to ensure the safety of 65 patients and professionals. 66

The most common intra-articular injections performed on haemophilia patients are 68 arthrocentesis, infiltration (with corticosteroids, local anaesthetics, hyaluronic acid or 69 platelet-rich plasma-PRP), and synoviorthesis (chemical or radioactive) [3,4]. All of 70 these invasive procedures require a prolonged period of contact with the patient and a 71 recovery period before discharge. Therefore, all these techniques must be performed 72 with the same level of protection. As a general rule, before the procedure and whenever 73 possible, face-to-face contact should be minimised by previously reviewing the 74 electronic history and having a telematic consultation. It will also be necessary for the 75 patient to sign an informed consent form adapted to the current epidemiological 76 scenario, so that the risks/benefits can be weighed [ 

This article is protected by copyright. All rights reserved significance of the tests will depend on the stage of the disease and on the quality and 83 origin of the sample. 84

The following guidelines are provided to help you understand the level of personal 86 protection needed in this care environment. In general, it is necessary to minimise the 87 time of exposure and limit the number of people in the room to the minimum personnel 88

needed. An assistant who has not had any contact with the patient should be present [8] . confirmed. There are techniques that should not be delayed, because of their risk of 106 producing irreversible damage, such as the aspiration of an acute painful major 107

This article is protected by copyright. All rights reserved haemarthrosis or the suspicion of septic arthritis. In these cases, the patient will also use 108 an FPP2 mask without a valve. Patients who present a clear risk (with symptoms or 109 epidemiological contacts) and in whom the tests cannot be performed should be treated 110 with the same level of protection as a COVID-19 patient [6, 9] . Table 1 

Known COVID-19-positive patients or those who present a clear risk (with symptoms or epidemiological contacts) should be postponed for the procedure whenever it is not essential Make a complete evaluation before indicating any new procedure. Whenever possible, face-toface contact should be minimised by previously reviewing the electronic history and having a telematic consultation

The patient should sign an informed consent form adapted to the current epidemiological scenario Consider replacing professionals who have a higher risk of complications from COVID-19

All personnel must be specifically trained to put on and dispose of PPE There should be separate pathways to keep suspected/infected patients separated from noninfected patients

The patient should be called in late in the day and ideally in a room prepared for the rest of the patients

Minimise the time of exposure and limit the number of people in the room to the minimum personnel needed Health care personnel must use complete PPE Patients should wear a surgical mask, gloves, and tights during their care All potential medication should be prepared and placed avoiding the manipulation of medication carts

The infusion of coagulation factor prior to the technique will be done in the same room as the procedure The use of corticosteroids should be discouraged if possible All the material potentially necessary for the procedure should be for single use and be available inside the room It is necessary to disinfect the puncture area with a hydroalcoholic chlorhexidine solution If anaesthesia is required, local techniques should be used whenever possible If technical equipment is used, such as ultrasound, it must be adequately protected

World Federation of Haemophilia

Surgical management of patients with COVID-19

Surgery in COVID-19 patients: Operational directives

Thermoregulation as a disease tolerance defense 210 strategy

This article is protected by copyright. All rights reserved (previous illnesses and possible sequelae derived from COVID-19 infection) allows. It 158 is essential to make a complete evaluation before indicating any new procedure. 159However, it should be noted that the acquisition of immunity after COVID-19 infection 160 has not been fully defined, and a low number of re-infections have been described. It 161 remains to be clarified whether these are false positive PCR tests (or previous false 162 negatives), or whether they are new mutations of the virus [6]. Table 1 

This article is protected by copyright. All rights reserved

All personnel must be specifically trained to take off the PPE The subsequent monitoring during recovery will be done in the same room as the procedureThe waste generated is considered class III, and must be disposed of as special biosanitary wasteCleaning and disinfection with viricides should be carried out between patients All centres must have adequate cleaning, disinfection and waste management protocols PWH: people with haemophilia; PEE: personal protective equipment 233 234